key: cord-0968484-f7hzmya6 authors: Hiller, Hugh M.; Taha, Sammy; Donham, Benjamin P.; Hackett, Anthony J. title: Community hospital experience in the emergency management of COVID‐19: Preventing morbidity and preserving resources date: 2020-09-13 journal: J Am Coll Emerg Physicians Open DOI: 10.1002/emp2.12251 sha: c6c63db00fa4a6d4e100995e8c5aa6117065d6ba doc_id: 968484 cord_uid: f7hzmya6 An incredible amount of information has been published regarding inpatient management of patients with COVID‐19. Although this is vitally important, critical interventions that occur in the emergency department (ED) can have a profound impact on the individual patient and the healthcare system as a whole. Much has been written regarding care in large centers, but there has been little discussion regarding similar patients in community settings. Prior to the pandemic, large centers were able to accept patients that outstripped the resources in community hospital settings, but currently we foresee that many community centers will begin to manage more complex cases without referral. As physicians in a medium‐sized community academic center, we aim to enumerate community‐hospital‐relevant guidance for ED care that focuses on adherence to available evidence‐based medicine, including early aggressive supplemental oxygenation, awake proning, and methods to improve oxygenation and ultimately delay intubation as long as safely possible. Equally importantly, it was recognized early that adjustments to medication regimens (eg, sedation) and personal protective equipment (PPE) use must be made in the ED to conserve those same resources for long‐term use in inpatient units and improve the functionality of the hospital system as a whole. It is our hope that this article may serve as a framework for similar community‐based hospitals to create their own protocols to optimize resource utilization, staff safety, and patient care. provider if possible • Goggles and/or face shield • Hair protection F I G U R E 1 Personal protective equipment (PPE) conservation algorithm, with escalating PPE recommendations for encounters with increased risk of transmission. This algorithm serves to protect patients and physicians while conserving resources transferred for further critical care. However, as tertiary centers are pushed to capacity, community hospital physicians will be forced to keep these patients for longer periods of time despite their significant limitations. This article is intended to serve as a framework for how to address such issues in a community ED. Protecting the individual physician and ancillary staff must remain the number one priority of community EDs. With an already limited number of available staff, illness among physicians and nurses will have devastating effects not only on departmental functionality, but also on morale as a whole. Furthermore, with limited PPE available, efforts must be made early to conserve as much equipment as possible to ensure supplies last as long as the pandemic continues. We recommend a stepwise approach to PPE conservation outlined in Figure 1 . First, a surgical mask must be worn by all patients and staff in the ED at the very minimum, because many patients may be asymptomatic or mildly symptomatic carriers. 1 In the early stages of disease progression, early aggressive non-invasive supplemental oxygenation is the cornerstone of management. 4 We advocate for a stepwise oxygenation plan as outlined in Figure 2 ; progressing from nasal cannula to a nonrebreather mask or the combination of the two, and then to high flow nasal cannula (HFNC) with the addition of awake proning. This only applies for those with preserved mental status who can protect their airways. It is paramount that the clinical appearance should inform management and not the degree of hypoxemia. Given concern for aerosolized spread of virus, caution must be used while oxygenation is being supported. All methods of oxygenation should be performed underneath a surgical mask, which decreases aerosolization. 5 We advocate for the use of either HFNC or mask oxygenation as non-invasive ventilation (NIV) modalities such as CPAP/BPAP increase aerosolization and should only be conducted in a dedicated COVID negative pressure area with maximal PPE. Although the use of HFNC in critically ill respiratory patients makes intuitive sense, it has failed to demonstrate a mortality benefit when used in all comers with respiratory failure. 6, 7 However, well-designed trials of HFNC demonstrate a mortality benefit in all types of pneumonia in comparison to standard oxygen and NIV. 8 Furthermore, HFNC has proven to decrease the rates of intubation that could have a profound impact on COVID-19 patients. 9 In trials of viral pneumonia leading to acute respiratory distress syndrome during the H1N1 pandemic, HFNC delayed or prevented intubation. 8 It seems reasonable to apply the principles garnered from previous outbreaks to treatment of critically ill patients with COVID-19 while we await more robust data specific to this disease. In mechanically ventilated acute respiratory distress syndrome patients, early prone ventilation has been shown to improve oxygenation and reduce mortality. 10 Physiologically, this strategy also applies in awake patients. Awake prone positioning has been shown to improve oxygenation and reduce rates of intubation in patients with acute respiratory distress syndrome secondary to viral pneumonia. 11 There is ample evidence to suggest that restriction of fluids, even in euvolemic patients, decreases overall time on mechanical ventilation in acute respiratory distress syndrome patients. [19] [20] [21] In practice, it seems that these same principles can be applied to COVID-19 patients to buy more time off of invasive mechanical ventilation. Although there remains great controversy regarding the use of diuretics in select patients, it seems prudent to limit fluids without the use of these medications except in extreme cases of fluid overload. 22 Unfortunately, this pandemic will not allow for traditional use of sedative medications due to the potentially large numbers of ventilated patients and waning supply of sedative medications, particularly at Sedation and analgesia goals as measured by externally validated behavioral assessment tools, the Richmond Agitation-Sedation Scale (RASS), and the Critical-Care Pain Observation Tool (CPOT), are targeted first using an opioid analgesic. 23, 25, 26 If goals are not met, a sedative medication is added, typically either propofol or dexmedetomidine. This RASS-centered sedation strategy can be seen illustrated in Figure 3C . In anticipation that we would run out of these sedative medications as the nation's need increased and our supplies dwindled, we developed strategies to preserve these medications. This included adding dosing regimens for alternative parenteral and enteral sedatives, analgesics, and antipsychotics as contingency options or as adjuncts to spare traditional parenteral sedation medications. 27 An example of our dosing regimen table can be seen in Figure S1 . Of note, this is merely an example, and all plans should be individualized to the specific ED and hospital system in close concert with pharmacy and critical care physicians. Clearly, all of the above is a constantly evolving plan depending on the number of ventilated patients, local and national drug shortages, and projected changes in patient volumes based on the latest epidemiologic predictions. In accordance with the recent data released from the RECOVERY trial that demonstrated a one-third reduction in deaths when used for those on invasive mechanical ventilation and a one-fifth reduction in deaths for those with hypoxia, we advocate for the use of dexamethasone in these patients. 28 For non-hypoxic patients, it appears there is little benefit and possibly harm associated with the use of dexamethasone. In regard to other therapies for COVID-19, there is not enough high quality evidence to advocate for additional therapies in the ED. Further discussion of therapeutics is outside the purview of this review. In conclusion, the COVID-19 pandemic has stressed the capacity of the healthcare system, and the community ED is no exception. However, with strict adherence to evidence-based medicine, aggressive oxygenation, awake proning, and conservation of medications and personal protective equipment, the ED can have a profound impact on the quality of care delivered. The views expressed are those of the authors and do not reflect the official policy or position of the Department of the Army, Department of Defense or the US Government. Asymptomatic transmission, the Achilles' heel of current strategies to control Covid-19 Centers for Disease Control and Prevention. Infection Control Guidance for Healthcare Professionals about Coronavirus Measurement of airborne particle exposure during simulated tracheal intubation using various proposed aerosol containment devices during the COVID-19 pandemic Clinical Management of COVID-19 Aerosol dispersion during various respiratory therapies: a risk assessment model of nosocomial infection to health care workers Association of noninvasive oxygenation strategies with all-cause mortality in adults with acute hypoxemic respiratory failure: a systematic review and meta-analysis High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis High-flow nasal therapy in adults with severe acute respiratory infection: a cohort study in patients with 2009 influenza A/H1N1v Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure Prone positioning in severe acute respiratory distress syndrome Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province Is the prone position helpful during spontaneous breathing in patients with COVID-19? Awake Pronation-A guest write-up by David Gordon Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19) Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Covid-19 in critically ill patients in the Seattle region-case series National heart, lung, and blood institute Acute Respiratory Distress Syndrome (ARDS) clinical trials network. comparison of two fluid-management strategies in acute lung injury Fluid management in acute respiratory distress syndrome Reducing the burden of acute respiratory distress syndrome: the case for early intervention and the potential role of the emergency department SARS-CoV-2 (COVID-19) and intravascular volume management strategies in the critically ill Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU Limiting sedation for patients with acute respiratory distress syndrome-time to wake up The effect of sedation protocol using Richmond Agitation-Sedation Scale (RASS) on some clinical outcomes of mechanically ventilated patients in intensive care units: a randomized clinical trial Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS) Enteral versus intravenous approach for the sedation of critically ill patients: a randomized and controlled trial Dexamethasone in hospitalized patients with Covid-19: preliminary report The authors declare no conflict of interest. Additional supporting information may be found online in the Supporting Information section at the end of the article.